To confirm ZDHHC13’s potential tumor-suppressive role in melanoma within an immunocompetent setting, we engineered B16 cells to overexpress ZDHHC13 via lentiviral transduction (Supplemental Figure 8C). The gene discussed is ZDHHC13; the disease is melanoma.